VEA
HRMY icon

Virtus ETF Advisers’s Harmony Biosciences HRMY Stock Holding History

Virtus ETF Advisers’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
29,253
+13,854
+90% +$437K 0.41% 52
2026
Q1 		$431K Buy
15,399
+2,875
+23% +$94.3K 0.2% 129
2025
Q4 		$469K Hold
12,524
– – 0.22% 118
2025
Q3 		$345K Hold
12,524
– – 0.19% 147
2025
Q2 		$396K Buy
12,524
+8,777
+234% +$282K 0.24% 112
2025
Q1 		$124K Sell
3,747
-7,228
-66% -$259K 0.08% 274
2024
Q4 		$378K Sell
10,975
-92
-0.8% -$3.16K 0.15% 189
2024
Q3 		$443K Hold
11,067
– – 0.21% 190
2024
Q2 		$334K Sell
11,067
-213
-2% -$6.41K 0.16% 206
2024
Q1 		$379K Buy
11,280
+1,623
+17% +$52.1K 0.2% 201
2023
Q4 		$312K Buy
9,657
+1,147
+13% +$32K 0.2% 220
2023
Q3 		$279K Sell
8,510
-1,099
-11% -$38.2K 0.17% 209
2023
Q2 		$338K Buy
9,609
+4,361
+83% +$151K 0.2% 170
2023
Q1 		$171K Buy
5,248
+89
+2% +$4.05K 0.09% 315
2022
Q4 		$284K Sell
5,159
-137
-3% -$7.53K 0.15% 291
2022
Q3 		$235K Buy
5,296
+78
+1% +$3.81K 0.09% 301
2022
Q2 		$254K Sell
5,218
-4,468
-46% -$201K 0.09% 294
2022
Q1 		$471K Hold
9,686
– – 0.21% 131
2021
Q4 		$413K Sell
9,686
-4,605
-32% -$184K 0.16% 139
2021
Q3 		$548K Sell
14,291
-1,312
-8% -$42.2K 0.24% 124
2021
Q2 		$440K Buy
15,603
+281
+2% +$8.43K 0.18% 184
2021
Q1 		$506K Buy
15,322
+423
+3% +$14.8K 0.21% 145
2020
Q4 		$539K Buy
+14,899
New +$601K 0.22% 136

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus ETF Advisers's HRMY Position: Q2 2026 in Review

Virtus ETF Advisers increased its Harmony Biosciences (HRMY) stake by 90% in Q2 2026, buying an estimated $437K and bringing the position to 29,253 shares worth $1.07M. The position accounts for 0.41% of the portfolio, ranked #52.

Virtus ETF Advisers first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Virtus ETF Advisers held 29,253 shares of Harmony Biosciences worth $1.07M as of Q2 2026.
  • Virtus ETF Advisers bought 13,854 Harmony Biosciences shares in Q2 2026, an estimated $437K.
  • Harmony Biosciences made up 0.41% of Virtus ETF Advisers's portfolio in Q2 2026, its #52 holding.
  • Virtus ETF Advisers first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.